TB-500 (Thymosin Beta-4)
Reported Onset
1–3 weeks
Primary Use
Systemic tissue regeneration, flexibility support, and wound healing.
Dose
2mg - 5mg
Frequency
2x weekly (loading), 1x weekly (maintenance)
ARA-290
Reported Onset
2–4 weeks
Primary Use
Tissue protection, neuropathy relief, and anti-inflammatory action.
Dose
4mg - 8mg
Frequency
Daily
Community Verdict
Both systemic repair peptides; ARA-290 targets nerve, TB-500 targets muscle/tissue. The community generally selects between TB-500 (Thymosin Beta-4) and ARA-290 based on their specific goals and experience. Both compounds are available through physician-supervised protocols at Alukard, where a physician can help determine which is most appropriate for your situation.
Get a Physician-Supervised Protocol for TB-500 (Thymosin Beta-4) or ARA-290 at Alukard
Community experiences are a starting point — but a physician-supervised protocol from Alukard gives you pharmaceutical-grade compounds, proper dosing, lab monitoring, and the safety of medical oversight.
MD
Supervised
GMP
Certified
Labs
Monitoring
COA
Verified